Loading...
Market
Story
Pine Labs Gets Singapore Court Approval to Shift Domicile and Operations to India
May 20, 2024, 06:27 AM
Pine Labs has received approval from a Singapore court to shift its base to India. The court's decision allows Pine Labs to merge its local entity in Singapore with its Indian unit and transfer all its assets and properties to India. The company is also moving its application simultaneously in the National Company Law Tribunal (NCLT) in India. This move will shift Pine Labs' domicile and operations to India.
View original story
Similar markets
Less than 5% • 33%
5-10% • 33%
More than 10% • 33%
Pinecone dominates >50% market share • 25%
Pinecone holds 25-50% market share • 25%
Pinecone holds 10-25% market share • 25%
Pinecone holds <10% market share • 25%
Less than 5% • 25%
5%-10% • 25%
10%-15% • 25%
More than 15% • 25%
Below 5% • 33%
5%-10% • 33%
Above 10% • 33%
Ozempic gains over 30% market share • 25%
Ozempic gains 10-30% market share • 25%
Ozempic gains less than 10% market share • 25%
Ozempic loses market share • 25%
Decrease in market share • 33%
No change in market share • 34%
Increase in market share • 33%
Yes • 50%
No • 50%
Below 20% market share • 33%
20-40% market share • 34%
Above 40% market share • 33%